| [1] |
Zhang Hanmei, Feng Suying.
Gut, skin, and oral microbiota in autoimmune bullous diseases
[J]. Chinese Journal of Dermatology, 2026, 59(9): 902-905.
|
| [2] |
Ji Xiang, Zhu Ping, Huang Shudai, Jiang Jiayi, Huang Kaixuan, Li Zhexi, Yang Xi, Wang Daguang.
Analysis of risk factors for autoimmune bullous diseases complicated by venous thromboembolism during hospitalization: a retrospective analysis
[J]. Chinese Journal of Dermatology, 2026, 59(8): 779-782.
|
| [3] |
Blistering Diseases Research Group, China “Belt and Road” Dermatology Alliance, Collaborative Group on Pemphigus/Bullous Pemphigoid Research, Chinese Society of Dermatology.
Expert consensus on the diagnosis and treatment of anti-p200 pemphigoid (2026 edition)
[J]. Chinese Journal of Dermatology, 2026, 59(5): 387-395.
|
| [4] |
Wang Caixia, Xu Fan, Shi Jing, Zhu Hailian, Lu Guiling, Wang Hongmei.
Efficacy and safety of omalizumab and dupilumab for the treatment of bullous pemphigoid: a systematic review
[J]. Chinese Journal of Dermatology, 2026, 59(3): 262-268.
|
| [5] |
Wang Yuan, Li Suo, Li Zhiliang, Jing Ke, Sun Chao, Liang Guirong, Zhang Hanmei, Feng SuyingHospital of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing , China.
Clinical application of combined serological diagnostic methods in anti-BP180-type and anti-laminin 332-type mucous membrane pemphigoid
[J]. Chinese Journal of Dermatology, 2025, 58(5): 446-452.
|
| [6] |
China Dermatologist Association, Treatment Group, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases, Rare Skin Diseases Committee, China Alliance for Rare Diseases.
Diagnosis and treatment of bullous pemphigoid: an expert consensus statement (2025 edition)
[J]. Chinese Journal of Dermatology, 2025, 58(5): 405-415.
|
| [7] |
Chen Yao, Yu Lang, Jiang Qian, Yu Huiyuan, Chen Liuqing, Chen Jinbo.
Comparison of optical coherence tomography imaging features between bullous pemphigoid and pemphigus
[J]. Chinese Journal of Dermatology, 2025, 58(3): 216-220.
|
| [8] |
Lan Zhiyi, Chen Zeyu, Zhao Zihan, Zhang Xilin, Gu Jun, Shi Yuling, .
Interleukin-27 exerts a protective effect against psoriasis by inhibiting the secretion of interleukin-17A from T cells: a mechanistic study
[J]. Chinese Journal of Dermatology, 2025, 58(11): 1034-1041.
|
| [9] |
Wei-Qi REN Ya-Ru ZOU Min PAN.
Risk factors for secondary infection in patients with bullous pemphigoid
[J]. Chinese Journal of Dermatology, 2024, 57(8): 770-772.
|
| [10] |
Hao Dan, Wang Yiyi, Xiao Yue, Yan Wei, Li Wei.
Systemic treatment options for psoriasis in special areas
[J]. Chinese Journal of Dermatology, 2024, 0(3): 20230190-e20230190.
|
| [11] |
Guo Lei, Cao Chunyan, Fang Xiaoya, Feng Suying.
Analysis of current status and risk factors of multidrug-resistant bacteria wound infections in patients with autoimmune bullous diseases
[J]. Chinese Journal of Dermatology, 2024, 57(2): 155-160.
|
| [12] |
Wang Gang.
Challenges and strategies for the treatment of bullous pemphigoid
[J]. Chinese Journal of Dermatology, 2024, 57(10): 887-890.
|
| [13] |
Chen Yan, Chen Danyang, Chen Xixue, Shang Panpan, Wang Mingyue.
Application of dupilumab in the treatment of 104 patients with bullous pemphigoid and analysis of factors influencing the efficacy
[J]. Chinese Journal of Dermatology, 2024, 57(10): 925-930.
|
| [14] |
Hu Junyu, Chen Danyang, Chen Xixue, Wang Mingyue.
Dupilumab combined with minocycline or with minocycline and systemic glucocorticoids for the treatment of bullous pemphigoid: a cohort study
[J]. Chinese Journal of Dermatology, 2024, 57(10): 917-924.
|
| [15] |
Li Suo, Jing Ke, Wang Yuan, Li Zhiliang, Zhao Chenjing, Zhang Hanmei, Liang Guirong, Feng Suying.
Clinical and immunoserological features of 35 cases of anti-p200 pemphigoid: a retrospective analysis
[J]. Chinese Journal of Dermatology, 2024, 57(10): 897-903.
|